Hint mode is switched on Switch off
For swift navigation between sections

Organization: Mirum Pharmaceuticals
LEI 254900YZKR40F7F27K81

Organization name
Mirum Pharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
316 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).

Awards

News

08/05/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28/02/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
11/01/2024 Mirum Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
08/01/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
18/12/2023 Mirum Pharmaceuticals: Other Events
All organization news

Documentation

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    254900YZKR40F7F27K81
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001759425
  • EIN
    83-1281555

Credit and ESG Ratings

Macroeconomic Indicators - Mirum Pharmaceuticals

Registration is required to get access.